Showing results (291-300 of 319) with videos related to
Sort By:
Pageof 32
Archives of General Psychiatry|October 1, 1990
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replicationF M Quitkin, P J McGrath, J W Stewart, et al.Archives of General Psychiatry|July 1, 1984
The tyramine challenge test as a marker for melancholiaW M Harrison, T B Cooper, J W Stewart, et al.Archives of General Psychiatry|April 1, 1991
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover designF M Quitkin, W Harrison, J W Stewart, et al.The Journal of Medicine and Philosophy|June 1, 1994
DMS-IV meets philosophyA Frances, A H Mack, M B First, et al.Human Reproduction (Oxford, England)|September 1, 1995
Immunohistochemical localization, identification and regulation of the interleukin-1 receptor antagonist in the human endometriumC Simón, A Frances, B Y Lee, et al.The American Journal of Psychiatry|November 14, 1997
Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjectsL A Papp, J M Martinez, D F Klein, et al.Psychiatry Research|February 1, 1988
Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variablesR P Brown, P M Stoll, P E Stokes, et al.Scientific Reports|September 15, 2023
Recombinant expression and subcellular targeting of the particulate methane monooxygenase (pMMO) protein components in plantsTatiana Spatola Rossi, A Frances Tolmie, Tim Nichol, et al.Journal of Clinical Psychopharmacology|June 1, 1992
Predictive value of symptoms of atypical depression for differential drug treatment outcomeP J McGrath, J W Stewart, W M Harrison, et al.The American Journal of Psychiatry|March 1, 1988
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI respondersF M Quitkin, J W Stewart, P J McGrath, et al.Pageof 32